News from IAS 2011

The 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) took place in Rome, Italy, 17-20th July, with more than 5000 delegates.

As the official online partner for scientific reporting, NAM published six free email bulletins, with original news reporting and links to abstracts.

The conference included an interesting and diverse collection of presentations and sessions, covering a broad range of subjects in the HIV field, including new treatment, prevention and practice research.

This year’s conference had a major focus on treatment as prevention and on the use of antiretrovirals as pre-exposure prophylaxis (PrEP).

All our news reports from the conference are listed here, for the summary bulletins in English, French, Spanish, Portuguese or Russian, visit our conference bulletin page.

aidsmap news from IAS 2011

HPTN 052: early treatment reduces serious illness by 40%

Early treatment in the HPTN 052 study of treatment as prevention reduced serious illness by around 40%, delegates at the Sixth International AIDS Society conference (IAS 2011)

Published
18 July 2011
By
Keith Alcorn
Treatment is prevention: HPTN 052 study shows 96% reduction in transmission when HIV-positive partner starts treatment early

Results from a trial showing that antiretroviral treatment prevents HIV from being passed onto uninfected partners received a standing ovation today at the Sixth International AIDS Society

Published
18 July 2011
By
Keith Alcorn
Bacterial vaginosis raises women's risk of transmitting HIV

A man who is in a relationship with an HIV-positive woman has a three times higher risk of acquiring HIV if his partner also has bacterial vaginosis,

Published
18 July 2011
By
Roger Pebody
Doubt remains if HIV therapy increases the risk of fragility fractures

The relationship between HIV therapy and fracture risk is far from straightforward, US research presented to the International AIDS Society conference (IAS 2011) in Rome suggests. An analysis

Published
18 July 2011
By
Michael Carter
Marker of cardiovascular disease also associated with bone problems in patients with HIV

An important marker of sub-clinical cardiovascular risk is associated with reduced bone mineral density in the hips of HIV-positive patients, according to Italian research presented to the Sixth

Published
18 July 2011
By
Michael Carter
The research agenda for antiretroviral prevention – now it gets complex

We now know that starting antiretroviral therapy early, pre-exposure prophylaxis (PrEP) and vaginal microbicides can all have an impact on HIV transmission, Victor de Gruttola told a satellite

Published
18 July 2011
By
Roger Pebody
Rome IAS conference is 'landmark moment' for HIV science, say experts

The Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) opened on Sunday night in Rome amid great excitement, with scientific

Published
17 July 2011
By
Keith Alcorn
Antiretroviral prevention methods 'not in competition' with each other

Antiretroviral prevention methods are not in competition, and policy makers and providers need to start to thinking about how antiretrovirals, pre-exposure prophylaxis and microbicides will be provided

Published
17 July 2011
By
Keith Alcorn
Careful monitoring still needed for patients with undetectable HIV while CD4s remain below 200

Patients whose CD4 cell count does not recover despite achieving virologic control with HIV therapy require continued medical attention, results of a large European study presented to

Published
01 July 2011
By
Michael Carter
← Prev1234Next →

Coverage of the conference from CCO

Clinical Care Options (CCO) is the other official online partner of the conference. It will be providing audio highlights, capsule summaries and downloadable slidesets and we will link to their coverage in our news and bulletins, so you can have the fullest picture of the conference.

"Ending the epidemic is scientifically doable"

From 'what if' to 'what now': implementing the new prevention technologies.

Read this news story >

Treatment is prevention

HPTN 052 study shows 96% reduction in transmission when HIV-positive partner starts treatment early.

Read this news story >

Hormonal contraception and HIV

Hormonal contraceptive use increases women’s risk of acquiring and transmitting HIV.

Read this news story >

PrEP works for women too

Pre-exposure prophylaxis does work for women, two studies find.

Read this news story >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.